The 5th mRNA-Based Therapeutics Summit Europe focuses on the latest advancements in mRNA therapeutics and vaccines, highlighting key R&D opportunities, clinical data, and commercialization strategies for mRNA-based medicines.
Topics
Visions for the Future of mRNA & Beyond: The Leadership Perspective
Showcasing New Discoveries in mRNA Medicine From Asia to Unlock Platforms for Obesity & Antibody Production
Deciphering a Regulatory Framework & Guidance for Future mRNA Platforms to Harmonise Clinical & Manufacturing Development
Turbocharging new mRNA-LNP Programs to Expand Therapeutic Potential with European Research Initiatives & Collaborations
Forging New Commercial Partnerships to Ensure Smooth Transfer into Trials & Manufacturing at Scale
Accelerating Effective & Safe Personalised mRNA Cancer Immunotherapies Towards Clinical Success & Achieving Market Approval
Advancing mRNA Vaccines & Therapies Towards the First Approval With Breaking First-InHuman Clinical Progress Data from Leaders in the Clinic
Turbocharging Antigen Selection & Design to Optimise mRNA Vaccine Safety & Tolerability for Emerging Infectious Diseases
Scale & Transfer – Leveraging Sustainable Platforms to Produce mRNA Products Effectively & Affordably for LMICs
Achieving Effective Cell & Tissue Targeting, Distribution & Translatability with Novel LNP Formulations
Assessing Safety, Measures & Pandemic Preparedness to Minimise Future Risks & Accelerate Response to Health Threats & Patient-Centric Decision Making
Disruptive Companies Unlocking Diseases of Tomorrow With New Models Systems & Bioinformatic Approaches
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic.By clicking "Accept", you consent to our use of cookies. You can manage your preferences or learn more by clicking "Customize" or visiting our Cookies Policy page.
